PT - JOURNAL ARTICLE AU - Lehmann, Christopher J AU - Dylla, Nicholas P AU - Odenwald, Matthew AU - Nayak, Ravi AU - Khalid, Maryam AU - Boissiere, Jaye AU - Cantoral, Jackelyn AU - Adler, Emerald AU - Stutz, Matthew R AU - Cruz, Mark Dela AU - Moran, Angelica AU - Lin, Huaiying AU - Sundararajan, Anitha AU - Sidebottom, Ashley M. AU - Pamer, Eric G AU - Aronsohn, Andrew AU - Fung, John AU - Baker, Talia B AU - Kacha, Aalok TI - Microbiome compositions and fecal metabolite concentrations predict post-operative infection in liver transplant recipients AID - 10.1101/2023.02.17.23286090 DP - 2023 Jan 01 TA - medRxiv PG - 2023.02.17.23286090 4099 - http://medrxiv.org/content/early/2023/02/18/2023.02.17.23286090.short 4100 - http://medrxiv.org/content/early/2023/02/18/2023.02.17.23286090.full AB - Background Liver transplantation (LT) is associated with postoperative infections caused by antibiotic-resistant bacterial pathogens that reside in the intestine. An intact intestinal microbiome suppresses expansion of enteric pathogens, however patients with severe liver disease often have reduced microbiome diversity and increased density of antibiotic-resistant Enterococcus and Enterobacterales species. (1–4) Experimental models have demonstrated that metabolites produced by the intestinal microbiome, including short chain fatty acids (SCFAs), secondary bile acids and indole compounds, enhance host epithelial and immune defenses against enteric pathogens.(5–10) Microbiome derived metabolites likely contribute to resistance against infectious diseases in LT patients, however, this remains uninvestigated.Methods We prospectively enrolled 107 liver transplant candidates and determined peri-transplant fecal microbiome compositions including relative and absolute fecal metabolite concentrations.Results Fecal microbiomes in LT recipients ranged from highly diverse to complete loss of diversity resulting in expansion of Enterococcus and/or Enterobacterales species that were associated with postoperative infection. Gas chromatographic (GC-) and liquid chromatographic (LC-) Mass spectrometric analyses revealed decreased concentrations of SCFAs, secondary bile acids, and indole compounds in fecal samples with low microbiome diversity and associated expansion of Enterococcus and Enterobacterales populations.Conclusion Fecal metabolite abundances accurately predicted LT patients with reduced microbial diversity and those who developed postoperative infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Duchossois Family Institute.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study received approval by the institutional review board at the University of Chicago for human subjects research (IRB20-0163). At the time of enrollment, all study procedures were explained and written informed consent was obtained from the subject and/or an approved surrogate decision maker. Healthy donors were identified separately from LT patients. Written informed consent was also obtained from HD prior to participation.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code are available on both Github (https://github.com/DFI-Bioinformatics/Microbiome_Liver_Transplant) and Zenodo (https://zenodo.org/badge/latestdoi/592530758). Shotgun metagenomic sequences can be found on NCBI via this accession number: PRJNA928758. https://github.com/DFI-Bioinformatics/Microbiome_Liver_Transplant https://zenodo.org/badge/latestdoi/592530758 https://www.ncbi.nlm.nih.gov/bioproject/PRJNA928758